Inactivated vaccine for chikungunya virus
AssigneeThe Government of the United States, as represented by the Secretary of the Army
InventorsStephen J. THOMAS, Kenneth H. ECKELS, Joseph R. PUTNAK, Richard G. JARMAN, III, Rafael Antonio DE LA BARRERA
Life of this patent
Estimating the term…
Abstract
The disclosure generally provides a purified inactivated chikungunya virus (CHIKV), methods for producing the purified inactivated CHIKV, immunogenic compositions and vaccines comprising the purified inactivated CHIKV and methods for the prevention and/or treatment of infection by CHIKV.
Claims16
A method for immunizing a mammal against a CHIKV, wherein the method comprises administering to the mammal an effective amount of the a composition comprising a purified inactivated chikungunya virus (CHIKV).
A method of eliciting a protective immune response in a human against a chikungunya virus (CHIKV) infection comprising administering a composition comprising an effective amount of a purified inactivated chikungunya virus.
The method of claim 9, wherein the administering is via a route selected from intramuscular injection, intradermal injection, subcutaneous injection, intravenous injection, oral, or intranasal.
Dependencies are inferred from the claim text.